Stay updated on Inhibitors for COVID-19 Clinical Trial

Sign up to get notified when there's something new on the Inhibitors for COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inhibitors for COVID-19 Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page’s footer “Revision” label has been incremented from v3.5.2 to v3.5.3, indicating a site/app revision rather than any update to the MATIS study record text.
    Difference
    0.0%
    Check dated 2026-04-24T05:41:51.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:01:34.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.5.0, replacing the prior v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T21:20:11.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T20:07:13.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    A new MATIS-related publication citation (Hazell et al., BMJ Open 2026) was added to the Publications section, and the page shows Revision: v3.4.2; a generic funding-status notice was removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:26:44.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with operating-status guidance and updated the site revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T04:10:59.000Z thumbnail image

Stay in the know with updates to Inhibitors for COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inhibitors for COVID-19 Clinical Trial page.